These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3723647)

  • 41. Treatment of phenytoin toxicity with repeated doses of activated charcoal.
    Weichbrodt GD; Elliott DP
    Ann Emerg Med; 1987 Dec; 16(12):1387-9. PubMed ID: 3688606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lack of effect of oral activated charcoal on imipramine clearance.
    Goldberg MJ; Park GD; Spector R; Fischer LJ; Feldman RD
    Clin Pharmacol Ther; 1985 Sep; 38(3):350-3. PubMed ID: 4028632
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cholestyramine as an adsorbent in acute lindane poisoning: a murine model.
    Kassner JT; Maher TJ; Hull KM; Woolf AD
    Ann Emerg Med; 1993 Sep; 22(9):1392-7. PubMed ID: 7689801
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of phenobarbitone poisoning with repeated oral administration of activated charcoal.
    Boldy DA; Vale JA; Prescott LF
    Q J Med; 1986 Nov; 61(235):997-1002. PubMed ID: 3659250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of delayed activated charcoal on acetaminophen concentration after simulated overdose of oxycodone and acetaminophen.
    Mullins M; Froelke BR; Rivera MR
    Clin Toxicol (Phila); 2009 Feb; 47(2):112-5. PubMed ID: 18787997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activated charcoal for pediatric poisonings: the universal antidote?
    Lapus RM
    Curr Opin Pediatr; 2007 Apr; 19(2):216-22. PubMed ID: 17496769
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of charcoal-drug ratio on antidotal efficacy of oral activated charcoal in man.
    Olkkola KT
    Br J Clin Pharmacol; 1985 Jun; 19(6):767-73. PubMed ID: 4027120
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevention of amlodipine absorption by activated charcoal: effect of delay in charcoal administration.
    Laine K; Kivistö KT; Laakso I; Neuvonen PJ
    Br J Clin Pharmacol; 1997 Jan; 43(1):29-33. PubMed ID: 9056049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adsorption effects of activated charcoal on metaldehyde toxicity in rats.
    Shintani S; Goto K; Endo Y; Iwamoto C; Ohata K
    Vet Hum Toxicol; 1999 Feb; 41(1):15-8. PubMed ID: 9949477
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Measures to reduce absorption in the treatment of intoxications].
    de Vries I; van Zoelen GA; van Riel AJ; Meulenbelt J
    Ned Tijdschr Geneeskd; 2005 Dec; 149(53):2964-8. PubMed ID: 16425848
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of digoxin cross-reacting substances in patients with acute yellow Oleander (Thevetia peruviana) poisoning, including the effect of activated charcoal.
    Roberts DM; Southcott E; Potter JM; Roberts MS; Eddleston M; Buckley NA
    Ther Drug Monit; 2006 Dec; 28(6):784-92. PubMed ID: 17164695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Use of activated charcoal in acute poisonings: clinical safety and factors associated with adverse reactions in 575 cases].
    Amigó M; Nogué S; Miró O
    Med Clin (Barc); 2010 Jul; 135(6):243-9. PubMed ID: 20537361
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Theophylline desorption from activated charcoal caused by whole bowel irrigation solution.
    Hoffman RS; Chiang WK; Howland MA; Weisman RS; Goldfrank LR
    J Toxicol Clin Toxicol; 1991; 29(2):191-201. PubMed ID: 2051506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Simulated acetaminophen overdose: pharmacokinetics and effectiveness of activated charcoal.
    Rose SR; Gorman RL; Oderda GM; Klein-Schwartz W; Watson WA
    Ann Emerg Med; 1991 Oct; 20(10):1064-8. PubMed ID: 1928875
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevention of toxicity from oral cocaine by activated charcoal in mice.
    Tomaszewski C; McKinney P; Phillips S; Brent J; Kulig K
    Ann Emerg Med; 1993 Dec; 22(12):1804-6. PubMed ID: 8239099
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevention of chloroquine absorption by activated charcoal.
    Neuvonen PJ; Kivistö KT; Laine K; Pyykkö K
    Hum Exp Toxicol; 1992 Mar; 11(2):117-20. PubMed ID: 1349217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activated charcoal in theophylline intoxication.
    Brashear RE; Aronoff GR; Brier RA
    J Lab Clin Med; 1985 Sep; 106(3):242-5. PubMed ID: 4031629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the efficacy of gastric lavage, ipecacuanha and activated charcoal in the emergency management of paracetamol overdose.
    Underhill TJ; Greene MK; Dove AF
    Arch Emerg Med; 1990 Sep; 7(3):148-54. PubMed ID: 1983801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.